MedTrace Logo

Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms

NCT04643275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-09-09

No results posted yet for this study

Summary

This study will evaluate the clinical safety and the performance of the BTL-899 device during the treatment of upper arms.

Conditions

  • Fat Burn

Interventions

DEVICE

BTL-899

Treatment with study device.

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-08-02
Completion
2021-09-02

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04643275 on ClinicalTrials.gov